Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Population Pharmacokinetic Quantification of CYP2D6 Activity in Codeine Metabolism in Ambulatory Surgical Patients for Model-Informed Precision Dosing ; volume:63 ; number:11 ; day:23 ; month:10 ; year:2024 ; pages:1547-1560 ; date:11.2024
Clinical pharmacokinetics ; 63, Heft 11 (23.10.2024), 1547-1560, 11.2024
- Urheber
-
Ashraf, Muhammad Waqar
Poikola, Satu
Neuvonen, Mikko
Kiiski, Johanna I.
Kontinen, Vesa K.
Olkkola, Klaus T.
Backman, Janne T.
Niemi, Mikko
Saari, Teijo I.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40262-024-01433-9
- URN
-
urn:nbn:de:101:1-2502042104312.747544944538
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ashraf, Muhammad Waqar
- Poikola, Satu
- Neuvonen, Mikko
- Kiiski, Johanna I.
- Kontinen, Vesa K.
- Olkkola, Klaus T.
- Backman, Janne T.
- Niemi, Mikko
- Saari, Teijo I.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling
Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
Precision dosing of risperidone and aripiprazole in the treatment of schizophrenia using a physiologically based pharmacokinetic approach: a focus on the genetic polymorphism of CYP2D6
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin
Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis
Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy
Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting
Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan
Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling
Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
Precision dosing of risperidone and aripiprazole in the treatment of schizophrenia using a physiologically based pharmacokinetic approach: a focus on the genetic polymorphism of CYP2D6
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin
Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis
Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy
Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting
Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan
Selecting the Best Pharmacokinetic Models for a Priori Model-Informed Precision Dosing with Model Ensembling
Physiologically based pharmacokinetic modelling of atomoxetine with regard to CYP2D6 genotypes
Model Informed Drug Development and Precision Dosing for Drug-Drug-Gene-Interactions : Application of Physiologically-Based Pharmacokinetic Modeling
Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
Precision dosing of risperidone and aripiprazole in the treatment of schizophrenia using a physiologically based pharmacokinetic approach: a focus on the genetic polymorphism of CYP2D6
Personalized Tuberculosis Treatment Through Model-Informed Dosing of Rifampicin
Model-Informed Precision Dosing to Reduce Vincristine-Induced Peripheral Neuropathy in Pediatric Patients: A Pharmacokinetic and Pharmacodynamic Modeling and Simulation Analysis
Pharmacokinetic Optimization of Everolimus Dosing in Oncology: A Randomized Crossover Trial
Personalized Antifungal Therapy Through Model-Informed Precision Dosing of Posaconazole
Application of physiologically based pharmacokinetic modeling for sertraline dosing recommendations in pregnancy
Towards model-informed precision dosing of piperacillin: multicenter systematic external evaluation of pharmacokinetic models in critically ill adults with a focus on Bayesian forecasting